|
| Eli Lilly gets FDA approval for ADHD drug Strattera |
8 May 08, 12:30 |
|
| BOSTON (Thomson Financial) - Eli Lilly & Co. said Thursday the Food and Drug Administration has approved its Strattera treatment for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. |
| more |
|
